Bionano Genomics, Inc. (BNGO)
1.48
-0.09
(-5.73%)
USD |
NASDAQ |
Oct 02, 16:00
1.49
+0.01
(+0.68%)
Pre-Market: 20:00
Bionano Genomics Enterprise Value : 13.71M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 13.71M |
| October 01, 2026 | 14.77M |
| September 30, 2026 | 14.66M |
| September 29, 2026 | 16.66M |
| September 28, 2026 | 16.07M |
| September 25, 2026 | 15.83M |
| September 24, 2026 | 16.19M |
| September 23, 2026 | 16.31M |
| September 22, 2026 | 17.72M |
| September 21, 2026 | 17.84M |
| September 18, 2026 | 16.66M |
| September 17, 2026 | 16.78M |
| September 16, 2026 | 14.07M |
| September 15, 2026 | 14.66M |
| September 14, 2026 | 11.95M |
| September 11, 2026 | 10.65M |
| September 10, 2026 | 10.42M |
| September 09, 2026 | 10.18M |
| September 08, 2026 | 10.42M |
| September 04, 2026 | 10.42M |
| September 03, 2026 | 10.89M |
| September 02, 2026 | 11.24M |
| September 01, 2026 | 10.65M |
| August 31, 2026 | 10.65M |
| August 28, 2026 | 10.06M |
| Date | Value |
|---|---|
| August 27, 2026 | 10.53M |
| August 26, 2026 | 10.53M |
| August 25, 2026 | 11.01M |
| August 24, 2026 | 10.65M |
| August 21, 2026 | 10.42M |
| August 20, 2026 | 10.53M |
| August 19, 2026 | 10.77M |
| August 18, 2026 | 10.18M |
| August 17, 2026 | 10.30M |
| August 14, 2026 | 10.18M |
| August 13, 2026 | 10.18M |
| August 12, 2026 | 10.42M |
| August 11, 2026 | 10.30M |
| August 10, 2026 | 9.946M |
| August 07, 2026 | 9.946M |
| August 06, 2026 | 9.239M |
| August 05, 2026 | 8.886M |
| August 04, 2026 | 9.475M |
| August 03, 2026 | 9.416M |
| July 31, 2026 | 8.886M |
| July 30, 2026 | 8.768M |
| July 29, 2026 | 9.121M |
| July 28, 2026 | 9.121M |
| July 27, 2026 | 9.004M |
| July 24, 2026 | 9.357M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 49.50B |
| Bio-Rad Laboratories, Inc. | 9.620B |
| Bruker Corp. | 11.29B |
| Danaher Corp. | 173.98B |
| Harvard Bioscience, Inc. | 75.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.423M |
| Revenue (Quarterly) | 8.171M |
| Total Expenses (Quarterly) | 15.59M |
| EPS Diluted (Quarterly) | -0.6429 |
| Gross Profit Margin (Quarterly) | 52.80% |
| Profit Margin (Quarterly) | -90.85% |
| Earnings Yield | -252.1% |
| Normalized Earnings Yield | -244.70 |